Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography
暂无分享,去创建一个
John Kornak | Lea T Grinberg | Gil D Rabinovici | Joel Kramer | Marilu Gorno-Tempini | Dennis W Dickson | K. Rankin | D. Dickson | L. Grinberg | J. Kramer | W. Seeley | H. Vinters | A. Boxer | G. Rabinovici | J. Kornak | M. Mendez | Suzee E Lee | P. Ghosh | C. Corbetta-Rastelli | M. Gorno-Tempini | S. Sha | Mario F Mendez | Adam L Boxer | Bruce L Miller | Harry V Vinters | Pia M Ghosh | William W Seeley | Katherine P Rankin | Sharon J Sha | Chiara Corbetta-Rastelli | Willian J Jagust | B. Miller | B. Miller
[1] J. Trojanowski,et al. Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls , 2013, Neuron.
[2] T. Mizutani,et al. Imaging of corticobasal degeneration syndrome , 2007, Neuroradiology.
[3] Wang Zhan,et al. Joint Assessment of Structural, Perfusion, and Diffusion MRI in Alzheimer's Disease and Frontotemporal Dementia , 2011, International journal of Alzheimer's disease.
[4] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[5] Maria Luisa Gorno-Tempini,et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. , 2006, Archives of neurology.
[6] A. Bava,et al. Corticobasal degeneration: structural and functional MRI and single-photon emission computed tomography , 2003, Neuroradiology.
[7] J. Trojanowski,et al. Clinicopathological correlations in corticobasal degeneration , 2011, Annals of neurology.
[8] Mark Hallett,et al. Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.
[9] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[10] D. Ellison. Neuropathology : a reference text of CNS pathology , 1998 .
[11] P. Lantos,et al. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.
[12] Cindee M. Madison,et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. , 2013, Brain : a journal of neurology.
[13] B L Miller,et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia , 2002, Neurology.
[14] J. Hodges,et al. Diagnostic criteria for corticobasal syndrome: a comparative study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[15] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[16] J. Kornak,et al. Amyloid Vs Fdg-pet in the Differential Diagnosis of Ad And , 2022 .
[17] B. Miller,et al. Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.
[18] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[19] R. Petersen,et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.
[20] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[21] John Q. Trojanowski,et al. Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[22] J. Grafman,et al. Alzheimer's disease presenting as corticobasal syndrome , 2006, Movement disorders : official journal of the Movement Disorder Society.
[23] E. Richardson,et al. Corticodentatonigral degeneration with neuronal achromasia. , 1968, Archives of neurology.
[24] Manjit,et al. Neurology , 1912, NeuroImage.
[25] L. Hakamies,et al. [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.
[26] G. Rabinovici,et al. Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications , 2011, Alzheimer's Research & Therapy.
[27] Seth Love,et al. Neuropathology: A Reference Text of CNS Pathology , 1998 .
[28] C. DeCarli,et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. , 2007, Brain : a journal of neurology.
[29] C. Rowe,et al. Clinical Profile of PiB-Positive Corticobasal Syndrome , 2013, PloS one.
[30] M. Doran,et al. Pathological heterogeneity of clinically diagnosed corticobasal degeneration , 2003, Journal of the Neurological Sciences.
[31] K Patterson,et al. Focal cortical presentations of Alzheimer's disease. , 2007, Brain : a journal of neurology.
[32] C. Jack,et al. Imaging correlates of pathology in corticobasal syndrome , 2010, Neurology.
[33] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] J. Trojanowski,et al. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia , 2011, Progress in Neurobiology.
[35] J. Hodges,et al. Is the pathology of corticobasal syndrome predictable in life? , 2009, Movement disorders : official journal of the Movement Disorder Society.
[36] William T. Hu,et al. Anatomical differences between CBS‐corticobasal degeneration and CBS‐Alzheimer's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[37] P. Ashby,et al. Cortical‐basal ganglionic degeneration , 1990, Neurology.
[38] Cindee M. Madison,et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.
[39] Bruce L. Miller,et al. C-reactive protein is related to memory and medial temporal brain volume in older adults , 2012, Brain, Behavior, and Immunity.
[40] J. Trojanowski,et al. Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.
[41] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.